Literature DB >> 36260239

Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.

Sakari Pöysti1, Firas Hamdan2,3,4, Elina A Tuovinen2,5,6, Kim My Le2,6, Salla Keskitalo7, Tanja Turunen7, Léa Minier2,8, Nanni Mamia2,6, Kaarina Heiskanen6,9, Markku Varjosalo7, Vincenzo Cerullo2,3,4, Juha Kere5,10,11, Mikko R J Seppänen2,6,12, Arno Hänninen1, Juha Grönholm13,14.   

Abstract

Abnormally high γδ T cell numbers among individuals with atypical SCID have been reported but detailed immunophenotyping and functional characterization of these expanded γδ T cells are limited. We have previously reported atypical SCID phenotype caused by hypomorphic IL2RG (NM_000206.3) c.172C > T;p.(Pro58Ser) variant. Here, we have further investigated the index patient's abnormally large γδ T cell population in terms of function and phenotype by studying IL2RG cell surface expression, STAT tyrosine phosphorylation and blast formation in response to interleukin stimulation, immunophenotyping, TCRvγ sequencing, and target cell killing. In contrast to his ⍺β T cells, the patient's γδ T cells showed normal IL2RG cell surface expression and normal or enhanced IL2RG-mediated signaling. Vδ2 + population was proportionally increased with a preponderance of memory phenotypes and high overall tendency towards perforin expression. The patient's γδ T cells showed enhanced cytotoxicity towards A549 cancer cells. His TCRvγ repertoire was versatile but sequencing of IL2RG revealed a novel c.534C > A; p.(Phe178Leu) somatic missense variant restricted to γδ T cells. Over time this variant became predominant in γδ T cells, though initially present only in part of them. IL2RG-Pro58Ser/Phe178Leu variant showed higher cell surface expression compared to IL2RG-Pro58Ser variant in stable HEK293 cell lines, suggesting that somatic p.(Phe178Leu) variant may at least partially rescue the pathogenic effect of germline p.(Pro58Ser) variant. In conclusion, our report indicates that expansion of γδ T cells associated with atypical SCID needs further studying and cannot exclusively be deemed as a homeostatic response to low numbers of conventional T cells.
© 2022. The Author(s).

Entities:  

Keywords:  Gamma-delta T-cell receptor; IL2RG; Interleukin receptor common subunit gamma; Severe combined immunodeficiency, atypical; X-linked combined immunodeficiency

Year:  2022        PMID: 36260239     DOI: 10.1007/s10875-022-01375-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  42 in total

Review 1.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  T+ NK+ IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency.

Authors:  Polina Stepensky; Baerbel Keller; Oded Shamriz; Caroline von Spee-Mayer; David Friedmann; Bella Shadur; Susanne Unger; Sebastian Fuchs; Adeeb NaserEddin; Nisreen Rumman; Sara Amro; Vered Molho Pessach; Omar Abuzaitoun; Raz Somech; Orly Elpeleg; Stephan Ehl; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2018-06-09       Impact factor: 8.317

3.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.

Authors:  Sebastian Fuchs; Anne Rensing-Ehl; Miriam Erlacher; Thomas Vraetz; Lara Hartjes; Ales Janda; Marta Rizzi; Myriam R Lorenz; Kimberly Gilmour; Geneviève de Saint-Basile; Chaim M Roifman; Steven Cheuk; Andrew Gennery; Adrian J Thrasher; Ilka Fuchs; Klaus Schwarz; Carsten Speckmann; Stephan Ehl
Journal:  Eur J Immunol       Date:  2014-08-28       Impact factor: 5.532

5.  Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization.

Authors:  P Mella; L Imberti; D Brugnoni; S Pirovano; F Candotti; E Mazzolari; A Bettinardi; M Fiorini; D De Mattia; B Martire; A Plebani; L D Notarangelo; S Giliani
Journal:  Clin Immunol       Date:  2000-04       Impact factor: 3.969

6.  Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests.

Authors:  Raz Somech; Chaim M Roifman
Journal:  J Pediatr       Date:  2005-10       Impact factor: 4.406

7.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

Authors:  William T Shearer; Elizabeth Dunn; Luigi D Notarangelo; Christopher C Dvorak; Jennifer M Puck; Brent R Logan; Linda M Griffith; Donald B Kohn; Richard J O'Reilly; Thomas A Fleisher; Sung-Yun Pai; Caridad A Martinez; Rebecca H Buckley; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

8.  Genetic study of a new X-linked recessive immunodeficiency syndrome.

Authors:  G de Saint-Basile; F Le Deist; M Caniglia; Y Lebranchu; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter.

Authors:  Anita Chandra; Fang Zhang; Kimberly C Gilmour; David Webster; Vincent Plagnol; Dinakantha S Kumararatne; Siobhan O Burns; Sergey Nejentsev; Adrian J Thrasher
Journal:  J Allergy Clin Immunol       Date:  2015-10-31       Impact factor: 10.793

10.  Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Capucine Picard; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2020-01-17       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.